Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) without driver alterations. A guideline update for patients with stage IV NSCLC with driver alterations will be publish...

Full description

Bibliographic Details

Published in:	Journal of clinical oncology Vol. 38; no. 14; p. 1608
Main Authors:	Hanna, Nasser H, Schneider, Bryan J, Temin, Sarah, Baker, Jr, Sherman, Brahmer, Julie, Ellis, Peter M, Gaspar, Laurie E, Haddad, Rami Y, Hesketh, Paul J, Jain, Dharamvir, Jaiyesimi, Ishmael, Johnson, David H, Leighl, Natasha B, Phillips, Tanyanika, Riely, Gregory J, Robinson, Andrew G, Rosell, Rafael, Schiller, Joan H, Singh, Navneet, Spigel, David R, Stabler, Janis O, Tashbar, Joan, Masters, Gregory
Format:	Journal Article
Language:	English
Published:	United States 10.05.2020
Subjects:	Carcinoma, Non-Small-Cell Lung - drug therapy Female Guidelines as Topic Humans Lung Neoplasms - drug therapy Male Neoplasm Staging
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!